CRBP
Corbus Pharmaceuticals Holdings, Inc.
Biotechnology · Healthcare · United States
4.22
close · 2026-10-30
value
10
cheaper than peers10
quality
34
stronger fundamentals34
ranked against
Biotechnology (pre-revenue)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.77× | 88 |
| earnings yield, 1 year ago | -87.2% | 24 |
| cash flow yield, 1 year ago | -51.2% | 24 |
| cash flow yield, 2 years ago | -44.2% | 24 |
| cash flow yield, 3 years ago | -46.0% | 22 |
| earnings yield, 3 years ago | -240.5% | 16 |
| cash flow yield, latest year | -79.0% | 15 |
| earnings yield, 2 years ago | -244.3% | 14 |
| earnings yield, latest year | -139.8% | 12 |
9 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 4.2% | 52 |
| operating margin | 0.0% | 50 |
| return on equity | -95.6% | 26 |
3 of 4 measures available
Facts
| market cap | $82M |
| free cash flow | -$43.3M |
| employees | 36 |
| first trade | 2014-10-27 |
| next earnings | 2026-08-06 |
| fundamentals updated | 2026-08-07 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 | 2021 |
| diluted eps | -5.90 | -3.68 | -10.31 | -10.15 | not reported |
| free cash flow | -$64.5M | -$41.8M | -$36.1M | -$37.6M | not reported |
| net income | -$78.5M | -$40.2M | -$44.6M | -$42.3M | not reported |
| revenue | $0 | $0 | $0 | $0 | not reported |
| unusual items | not reported | not reported | $8,519 | -$5.3M | $279,092 |